Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > now what ?
View:
Post by mirmirmir on Dec 15, 2024 2:41pm

now what ?

Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT
Start dateMay 12, 2023


End date Dec 01, 2024 
Comment by august202013 on Dec 15, 2024 7:19pm
Well Mirmirmir Now we wait for Big Brother new administration in January 2025 and locally HC for their respective approval/ok just like waiting for the covid-19 new test kit submitted on 29 November, 2020 for Big Brother and locally for another test results for the syphlilis accordingly by January, 2025 just like for the COVID-19 which was NEVER EVER APPROVED during 2019 to date ! Back to ...more  
Comment by mirmirmir on Dec 16, 2024 7:12am
the first time Medmira did this trial the following results caused a second trial to be carried put ,  The sensitivity of the Reveal Rapid TP Antibody POCT to detect treponemal antibodies was 95.0% in those with active syphilis but was only 25.0% in those with past syphilis.   overall Results: The Reveal Rapid TP Antibody POCT showed an overall sensitivity of 95.0% and a ...more  
Comment by mirmirmir on Dec 16, 2024 10:09am
MedMira Inc. Multiplo® Complete Syphilis (TP/nTP) Antibody Test (POCT)Start dateAug 26, 2024 End dateAug 26, 2025   gov ID NCT06586905
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities